ZUNITRA 4MG INJECTION

Zunitra 4 mg injection contains the active ingredient Zoledronic Acid. It is a member of the family of substances known as bisphosphonates. It’s used to decrease the calcium content of the blood of adult patients who have it excessively due to the presence of tumors. Tumors may accelerate normal bone morphology, where calcium release from the bone increases. This is known as tumor-induced high calcium (TIH). It can also be utilized to avoid bone-related complications for adult patients suffering from multiple myeloma as well as bone metastases caused by cancerous solid tumors (spread in cancer that extends from the site of origin onto the bone), as well as a conventional cancer treatment.
Zunitra 4 mg injection is also recommended to treat or prevent osteoporosis (a condition in which bones are weak and thin and easily break) for women who have experienced menopausal change. It can also be employed to combat osteoporosis among men. It’s utilized to treat Paget’s Disease of bones (a condition where the bones are weak and soft and can be damaged or painful. They can also be easily fractured). Other applications include preventing or treating osteoporosis in women and men who take glucocorticoids (a corticosteroid medication that can lead to osteoporosis).
Do not use this medicine if you’re sensitive to zoledronic acid or another bisphosphonate, other ingredients in this medicine, or pregnancy or nursing. Before starting treatment, tell your doctor whether you suffer from liver or kidney issues or bone conditions and swelling, pain, or jaw the sensation of numbness. This medication is not recommended for use by adolescents or children younger than 18 years old. Zunitra 4 mg injection is not chemotherapy for cancer and cannot slow down or stop the growth of cancer. It can, however, be used to treat bone disorders in cancer patients.